🇺🇸 FDA

Intelligence · Patent portfolio

S.L Patents

Full USPTO pharma patent portfolio for S.L — grant dates, expiration, and drug cross-links.

Patents
179
Expiring ≤24m
16

Quick answer

S.L has 179 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 16 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 4

  1. US 8563026

    Protein-based artificial retinas

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8545927

    Lactoferrin-based biomaterials for tissue regeneration and drug delivery

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8507012

    Formulations comprising extracts from primitive plant species (mosses, ferns and lichens) to treat and prevent cancers

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8461155

    Sclerostin and the inhibition of WNT signaling and bone formation

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8455493

    Imidazopyrazine Syk inhibitors

    Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8450321

    6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8440667

    Imidazopyrazine Syk inhibitors

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8426432

    Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8410097

    Heteropyrrole analogs acting on cannabinoid receptors

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8410078

    Composition and methods to treat cardiac diseases

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8372800

    Albumin-free factor VIII formulations

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8349609

    Differentiation of human embryonic and induced pluripotent stem cells

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8247550

    Certain substituted amides, method of making, and method of use thereof

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8222421

    Certain substituted ureas, as modulators of kinase activity

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8202893

    Cannabinergic lipid ligands

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8163520

    Nucleic acids encoding a chimeric polypeptide comprising IL-7 and HGF-beta chain and methods of use

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8163953

    Compounds for lysosomal modulation and methods of use

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8153116

    Use of conditional plasmodium strains lacking an essential gene in malaria vaccination

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8128921

    Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8124084

    Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15Ra

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8084451

    Heteropyrrole analogs acting on cannabinoid receptors

    Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8084095

    Ceramic/structural protein composites and method of preparation thereof

    Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8071118

    Method of inducing cell proliferation using fibroin

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8058226

    Albumin-free factor VIII formulations

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8058446

    Certain substituted amides, method of making, and method of use thereof

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8029808

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7976936

    Endoprostheses

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7955596

    B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production

    Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7838562

    Methods of inhibiting vascular permeability and apoptosis

    Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7741365

    Peripheral cannabinoid receptor (CB2) selective ligands

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7727542

    Bioactive materials, methods of making bioactive materials and method of use thereof

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7723300

    Regulators of the non-genomic action of progesterone and methods of use

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7717728

    Electrical Connector

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7687500

    Substituted oxetanes, method of making, and method of use thereof

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7666867

    Heteroindanes: a new class of potent cannabimimetic ligands

    Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7666842

    Elastin peptide analogs and uses thereof

    Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7666581

    Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease

    Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7658551

    Optical fiber connector

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7589220

    Inhibitors of the anandamide transporter

    Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7578998

    Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use

    Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7449557

    Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy

    Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7393842

    Pyrazole analogs acting on cannabinoid receptors

    Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7351827

    Substituted oxetanes, method of making, and method of use thereof

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7329651

    Cannabimimetic ligands

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7285683

    Bicyclic and tricyclic cannabinoids

    Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7285363

    Photoactivators, methods of use, and the articles derived therefrom

    Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7250169

    Anti-tumor activity of Ea-4-peptide of pro-IGF-1

    Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7247707

    Albumin-free factor VIII formulations

    Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does S.L have?

179 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do S.L patents expire?

16 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.